Lv4
426 积分 2026-01-05 加入
LncRNAs and the cancer epitranscriptome: Mechanisms and therapeutic potential
11分钟前
待确认
The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting
28分钟前
已完结
Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release
4个月前
已完结
Radioactive iodine for differentiated thyroid carcinoma
9个月前
已关闭
Targeting NF-κB in Hepatic Ischemia–Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting
9个月前
已完结
Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook
9个月前
已完结
Molecular alterations in Hürthle cell nodules and preoperative cancer risk
9个月前
已完结
Clinical impact of follicular oncocytic (H ̈urthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
9个月前
已完结
Role of 18FDG PET/CT in aggressive histological sub-categories of thyroid cancer (Hurthle cell carcinoma and poorly differentiated)
10个月前
已关闭
Role of 18FDG PET/CT in aggressive histological sub-categories of thyroid cancer (Hurthle cell carcinoma and poorly differentiated)
10个月前
已关闭